Tag archive for ‘Pharma Industry News’
By businessnewstoday On Tuesday, October 31st, 2017

Novartis to buy nuclear medicine company Advanced Accelerator Applications

(adsbygoogle = window.adsbygoogle || []).push({}); Pharma acquisition news : Novartis, the Switzerland-based global healthcare company will acquire Advanced Accelerator Applications (AAA), a French radiopharmaceutical More...

By businessnewstoday On Sunday, October 15th, 2017

Lupin acquires Symbiomix to strengthen women’s health specialty business

Lupin acquires Symbiomix Therapeutics : Generics pharma company Lupin based in Mumbai has announced the acquisition of Symbiomix Therapeutics through its US subsidiary in a $150 million deal to grow its women’s More...

By businessnewstoday On Saturday, August 26th, 2017

Novo Nordisk wins FDA approval of Victoza for heart diseases in type 2 diabetes

FDA approval of Victoza : Danish pharma giant Novo Nordisk diabetes drug Victoza (liraglutide) has been approved by the U.S. Food and Drug Administration (FDA) for treating heart diseases in type 2 diabetes patients. Victoza More...

By businessnewstoday On Tuesday, May 2nd, 2017

Two dead, four injured in Vizag pharma city explosion

Vizag fire accident news : A fire accident at the Jawaharlal Nehru Pharma City near Visakhapatnam on Tuesday left two employees dead and four injured who had survived burn injuries. The incident happened after a More...

By businessnewstoday On Tuesday, April 25th, 2017

Online pharmacies and healthcare services in the UK fail to meet safety standards

A number of online pharmacies and healthcare services in the UK have recently been suspended or warned, after undertaking lax healthcare practices and endangering patients. Doctors and pharmacies are allowed to More...

By businessnewstoday On Sunday, April 23rd, 2017

Sawai Pharmaceutical to acquire generic pharma business of Upsher-Smith

Japanese pharma company Sawai Pharmaceutical will acquire American generic drug maker Upsher‐Smith Laboratories’s generic pharma business for nearly $1.05bn from Acova. The generic drug portfolio of Upsher-Smith’s More...